Literature DB >> 10471358

Chromosomal, in silico and in vitro expression analysis of cardiovascular-based genes encoding zinc finger proteins.

K S Dai1, C C Liew.   

Abstract

Three hundred and sixty expressed sequence tags (ESTs) from human heart cDNA libraries corresponding to one hundred and twenty six unique zinc finger proteins (ZFPs) were annotated and classified into seven types of ZFPs as reported previously. Among these 126 cvbZFPs (cardiovascular-based ZFPs), the C(2)H(2)-type and the C(2)C(2)-type are the two major ZFP types which account for more than 80% of ZFP genes present in the cardiovascular system. The expression patterns of 11 randomly selected ZFP genes (at least one for each type) in normal fetal, adult and hypertrophic adult hearts, respectively, were determined using reverse transcriptase-polymerase chain reaction (RT-PCR) analysis. The results suggest that ZFPs may be involved in the processes of either developmental control (downregulated or upregulated expression) or basic cellular functional regulation (constant expression). Interestingly, PAF-1 (peroxisome assembly factor-1), a C(3)HC(4)-type ZFP (RING domain-containing ZFP) showing a downregulated expression pattern in normal tissues was found to be upregulated in hypertrophic adult heart, suggesting a possible role for this fetal gene in the pathogenesis of cardiac hypertrophy. In silico Northern analysis of 15 tissues showed that over 90% of cvbZFPs demonstrate widespread tissue distribution, suggesting the vast majority of ZFPs are functionally shared among tissues. The potential importance of transcriptional repressors in cardiovascular development and disease, such as HFHZ, was supported by the observation that one-third (39 of 126) of cvbZFPs possess this function. Of these, 26 are C(2)H(2)-type and the remaining 13 included 8 C(2)C(2)-type, 1 C(3)HC(4)-type, 1 C(2)HC(4)C(HD)-type, 2 C(3)H-type and 1 combination type. Of particular interest was the observation that ZFPs which contain a KRAB domain are the major subtype present (51. 3% of the total repressors in cvbZFPs). Chromosomal distribution analysis showed that mapping loci of cvbZFP genes are concentrated on chromosomes 1, 3, 6, 8, 10, 11, 12, 19 and X. In particular, chromosome 19 appears to be enriched in ZFP genes with C(2)H(2)-type as the predominant type present. Overall, this report provides a fundamental initial step toward understanding the potential role of ZFPs in regulating cadiac development and disease. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10471358     DOI: 10.1006/jmcc.1999.1011

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  5 in total

1.  Isolation and characterization of a novel zinc finger gene, ZNFD, activating AP1(PMA) transcriptional activities.

Authors:  Chen Lei; Qingmei Liu; Weiping Wang; Jun Li; Fengqin Xu; Yuanze Liu; Jiajia Liu; Shiliang Wu; Minghua Wang
Journal:  Mol Cell Biochem       Date:  2010-02-18       Impact factor: 3.396

2.  Activation of transcriptional activity of HSE by a novel mouse zinc finger protein ZNFD specifically expressed in testis.

Authors:  Fengqin Xu; Weiping Wang; Chen Lei; Qingmei Liu; Hao Qiu; Vinaydhar Muraleedharan; Bin Zhou; Hongxia Cheng; Zhongkai Huang; Weian Xu; Bichun Li; Minghua Wang
Journal:  Mol Cell Biochem       Date:  2012-01-10       Impact factor: 3.396

3.  Epigenetic regulation of human β-defensin 2 and CC chemokine ligand 20 expression in gingival epithelial cells in response to oral bacteria.

Authors:  L Yin; W O Chung
Journal:  Mucosal Immunol       Date:  2011-01-19       Impact factor: 7.313

4.  Progress in oral personalized medicine: contribution of 'omics'.

Authors:  Ingrid Glurich; Amit Acharya; Murray H Brilliant; Sanjay K Shukla
Journal:  J Oral Microbiol       Date:  2015-09-04       Impact factor: 5.474

5.  Identification of the DNA binding element of the human ZNF300 protein.

Authors:  Hongling Qiu; Lu Xue; Li Gao; Huanjie Shao; Di Wang; Mingxiong Guo; Wenxin Li
Journal:  Cell Mol Biol Lett       Date:  2008-03-18       Impact factor: 5.787

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.